Presentation Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents February 13, 2017 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Coronary ACS/AMI DES/BRS/DCB Factoid Up Next Presentation Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD Presenter: Jens Wiebe February 16, 0017 More slides + Presentation Mitral Valve 2017 Prognosis of Tricuspid Regurgitation in the Era of Transcatheter Interventions Presenter: Thomas Modine February 07, 2017 Presentation Mitral Valve 2017 Overview of Transcatheter Mitral Valve Repair Outcomes Presenter: Saibal Kar February 06, 2017 We Recommend
Presentation Everolimus-Eluting Versus Novolimus-Eluting Bioresorbable Scaffolds for CAD Presenter: Jens Wiebe February 16, 0017
Presentation Mitral Valve 2017 Prognosis of Tricuspid Regurgitation in the Era of Transcatheter Interventions Presenter: Thomas Modine February 07, 2017
Presentation Mitral Valve 2017 Overview of Transcatheter Mitral Valve Repair Outcomes Presenter: Saibal Kar February 06, 2017